Theratechnologies annonce un risque dinterruption temporaire de lapprovisionnement dEGRIFTASV au dbut de 2025
| THTX Stock | USD 1.18 0.04 3.28% |
Slightly above 67% of Theratechnologies' investor base is looking to short. The analysis of overall sentiment of trading Theratechnologies stock suggests that many investors are alarmed at this time. Theratechnologies' investing sentiment can be driven by a variety of factors including economic data, Theratechnologies' earnings reports, geopolitical events, and overall market trends.
Theratechnologies |
MONTRAL, 17 sept. 2024 -- Theratechnologies Inc. , une...
Read at globenewswire.com
 |
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Theratechnologies is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| VRCA | Verrica Pharmaceuticals | 11.71 | ||||
| PEPG | PepGen | 6.69 | ||||
| VIGL | Vigil Neuroscience | 4.55 | ||||
| BCAB | Bioatla | 4.46 | ||||
| VINC | Vincerx Pharma | 4.00 | ||||
| TARS | Tarsus Pharmaceuticals | 2.38 | ||||
| OPT | Opthea | 1.83 | ||||
| CNTA | Centessa Pharmaceuticals | 1.73 | ||||
| IVA | Inventiva | 1.52 | ||||
| GNFT | Genfit | 0.95 | ||||
| STTK | Shattuck Labs | 0.93 | ||||
| PMVP | Pmv Pharmaceuticals | 0.63 | ||||
| NUVL | Nuvalent | 0.48 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| MNOV | MediciNova | 3.37 | ||||
| LYRA | Lyra Therapeutics | 5.00 | ||||
| PHVS | Pharvaris | 7.49 | ||||
| APLT | Applied Therapeutics | 16.06 |
Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.